Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039709 | SCV000063398 | uncertain significance | not specified | 2015-11-30 | criteria provided, single submitter | clinical testing | proposed classification - variant undergoing re-assessment, contact laboratory |
ARUP Laboratories, |
RCV000039709 | SCV000604605 | uncertain significance | not specified | 2016-10-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000734148 | SCV000729387 | uncertain significance | not provided | 2024-10-07 | criteria provided, single submitter | clinical testing | Identified in a cohort of individuals with syndromic and nonsyndromic blindness (PMID: 32483926); patient clinical information not provided; In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 32483926, 15537665) |
Eurofins Ntd Llc |
RCV000734148 | SCV000862268 | uncertain significance | not provided | 2018-07-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000734148 | SCV001412179 | likely benign | not provided | 2024-11-18 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001273395 | SCV001456429 | uncertain significance | Usher syndrome type 1F | 2020-01-07 | no assertion criteria provided | clinical testing |